Wilms Tumor 1 (WT1) (N-Term) Peptide
WT1
Reactivité: Humain
Hôte: Synthetic
WB, BP
N° du produit ABIN8115891
168,15 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination:
France
Envoi sous 6 à 9 jours ouvrables
Aperçu rapide pour Wilms Tumor 1 (WT1) (N-Term) Peptide (ABIN8115891)
Antigène
WT1
(Wilms Tumor 1 (WT1))
Origine
Humain
Source
Synthetic
Application
Western Blotting (WB), Blocking Peptide (BP)
-
-
Protein Region
- N-Term
-
Fonction
- WT1 Peptide - N-terminal region
-
Séquence
- DFAPPGASAY GSLGGPAPPP APPPPPPPPP HSFIKQEPSW GGAEPHEEQC
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
This is a synthetic peptide designed for use in combination with anti-WT1 Antibody (ARP30967_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- WT1 (Wilms Tumor 1 (WT1))
-
Sujet
- WT1 is a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a small subset of patients with Wilm's tumors. Multiple transcript variants, resulting from alternative splicing at two coding exons, have been well characterized. There is also evidence for the use of non-AUG (CUG) translation initiation site upstream of, and in-frame with the first AUG, leading to additional isoforms.
-
Poids moléculaire
- 47kDa
-
ID gène
- 7490
-
UniProt
- P19544
Antigène
-
Vous êtes ici:
